FIELD: biotechnology.
SUBSTANCE: invention relates to an aptamer specifically binding to a nerve growth factor (NGF), and can be used in medicine as an anti-inflammatory or analgesic. The invention allows to obtain an aptamer capable of forming a secondary structure represented by the formula (I), where N is nucleotid selected from the group consisting of A, G, C and U. Each of N14 and N24, N31 and N41, and N39 and N49 forms a Watson-Cric base pair, and the remaining nucleotides of formula (I) are capable of forming a stalk structure.
EFFECT: invention provides an aptamer capable of inhibiting NGF activity at IC50 1 nM or less.
5 cl, 5 dwg, 5 tbl, 18 ex
Authors
Dates
2017-10-12—Published
2012-09-28—Filed